Dcaf15-KO 基因敲除小鼠

1. Pech, Matthew F, Fong, Linda E, Villalta, Jacqueline E, Jan, Calvin H, Settleman, Jeffrey. 2019. Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance. In eLife, 8, . doi:10.7554/eLife.47362. https://pubmed.ncbi.nlm.nih.gov/31452512/

2. Dong, Xiao, Han, Yang, Zhang, Encheng, Zhong, Lin, Li, Qi. 2021. Tumor suppressor DCAF15 inhibits epithelial-mesenchymal transition by targeting ZEB1 for proteasomal degradation in hepatocellular carcinoma. In Aging, 13, 10603-10618. doi:10.18632/aging.202823. https://pubmed.ncbi.nlm.nih.gov/33833131/

3. Xu, Yuewei, Spear, Sarah, Ma, Yurui, Keun, Hector C, Nijhuis, Anke. 2023. Pharmacological depletion of RNA splicing factor RBM39 by indisulam synergizes with PARP inhibitors in high-grade serous ovarian carcinoma. In Cell reports, 42, 113307. doi:10.1016/j.celrep.2023.113307. https://pubmed.ncbi.nlm.nih.gov/37858464/